NASDAQ | ETF
The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies.
The manager defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 15.19% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 6.82% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 4.26% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.98% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.72% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.71% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 2.59% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 2.19% |
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 2.01% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 1.98% |
| DYN | Dyne Therapeutics Inc | Healthcare | Biotechnology | 1.89% |
| BDX | Becton Dickinson and Company | Healthcare | Medical Instruments & Supplies | 1.89% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.61% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 1.55% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 1.54% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 1.53% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 1.51% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 1.48% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 1.41% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.40% |